Repeatability of tumor blood flow quantification with 82Rubidium PET/CT in prostate cancer — a test-retest study
Abstract Background Non-invasive tumor blood flow (TBF) quantification is a candidate approach for risk stratification and monitoring of prostate cancer patients. Validation data have recently been published on prostate TBF measurement with the widely used positron emission tomography (PET) flow tra...
Main Authors: | Mads Ryø Jochumsen, Kirsten Bouchelouche, Katrine Bødkergaard Nielsen, Jørgen Frøkiær, Michael Borre, Jens Sörensen, Lars Poulsen Tolbod |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-07-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-019-0529-2 |
Similar Items
-
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness
by: Mads Ryø Jochumsen, et al.
Published: (2021-02-01) -
Story of rubidium-82 and advantages for myocardial perfusion PET imaging
by: Jean-Francois eChatal, et al.
Published: (2015-09-01) -
Positron emission tomography rubidium-82 myocardial perfusion imaging in diagnosing uncommon paediatric acute coronary syndrome: a case report
by: Nadiah Abd Razak, et al.
Published: (2023-08-01) -
Reliability of rubidium-82 PET/CT for renal perfusion determination in healthy subjects
by: Stine Sundgaard Langaa, et al.
Published: (2022-11-01) -
Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease
by: Maroua Mimouni, et al.
Published: (2023-02-01)